{
  "meta": {
    "title": "Congenital_And_Developmental_Anomalies",
    "url": "https://brainandscalpel.vercel.app/congenital-and-developmental-anomalies-f11341cd.html",
    "scrapedAt": "2025-11-30T14:13:38.703Z"
  },
  "questions": [
    {
      "text": "A 65-year-old man presents to the primary care clinic for his yearly examination. Since being seen last year, the patient has become progressively more fatigued and experiences shortness of breath with exertion. He was hospitalized four times in the past year for three episodes of pneumonia and one episode of left leg cellulitis. The patient has noticed easy bruising and frequent bleeding when brushing his teeth and shaving. Two weeks ago, he developed a small wound on his right forearm, and it took over one week to start healing. The patient has a history of paroxysmal atrial fibrillation and takes metoprolol and warfarin. Vital signs show mild tachycardia. On physical examination, there is conjunctival pallor. There are diffuse scattered petechiae and small ecchymoses on skin examination and a 2 cm healing wound on the right forearm. Which of the following is the most likely diagnosis? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Myelodysplastic syndrome"
        },
        {
          "id": 2,
          "text": "Heparin-induced thrombocytopenia"
        },
        {
          "id": 3,
          "text": "Beta-thalassemia minor"
        },
        {
          "id": 4,
          "text": "Lead poisoning"
        },
        {
          "id": 5,
          "text": "Bernard-Soulier syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient presents with fatigue and shortness of breath with exertion in addition to easy bruising and bleeding. Additionally, he has had several bacterial infections and poor wound healing. This presentation raises concern for <strong>pancytopenia</strong>. Patients aged 60 years and older presenting with signs and symptoms of pancytopenia should be evaluated for <strong>myelodysplastic syndrome</strong>. This patient should have a <strong>complete blood count (CBC)</strong> to assess the hematologic cell lines and to guide further workup.<br><br><strong>Myelodysplastic syndrome (MDS)</strong> refers to a group of hematologic malignancies characterized by <strong>impaired hematopoiesis</strong>. All three cell lines (white blood cells, red blood cells, platelets) can have abnormal morphology, abnormal function, or abnormal numbers (<strong>cytopenia</strong>). Patients with suspected MDS should have a thorough history to evaluate for prior <strong>environmental exposures</strong> (e.g. benzene), <strong>chemotherapy</strong>, or <strong>prior radiation therapy</strong>.<br><br>History of <strong>recurrent bacterial infections</strong> can indicate leukopenia (especially neutropenia). <strong>Easy or persistent bleeding while shaving or brushing teeth</strong> suggests thrombocytopenia. New <strong>fatigue and exertional shortness of breath</strong> without another obvious cause (e.g. congestive heart failure) may indicate anemia. Physical examination may demonstrate signs of cytopenias, including conjunctival pallor, tachycardia, petechiae, and ecchymoses.<br><br>Whenever MDS is suspected, other causes of cytopenias should first be investigated. If clinical suspicion remains for MDS, then a <strong>peripheral blood smear </strong>and <strong>bone marrow biopsy (aspiration)</strong> should be performed. If MDS is confirmed, further cytogenetic and molecular testing should be performed to determine treatment. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Myelodysplastic syndrome:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Heparin-induced thrombocytopenia:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: HIT can occur in patients taking heparin or heparin-like medications and can lead to both bleeding and clotting. This patient&#8217;s warfarin would not cause HIT, and it would not explain the frequent infections or signs and symptoms of anemia that are present on bloodwork. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Beta-thalassemia minor:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Patients with beta-thalassemia minor have a heterozygous mutation that causes underproduction of hemoglobin beta-chains. Patients with Beta-thalassemia minor are typically asymptomatic. This patient&#8217;s presentation suggests significant pancytopenia, which beta-thalassemia minor would not explain. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Lead poisoning:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Lead poisoning is more common in children and in patients living in old houses with old, chipped paint. It typically causes microcytic anemia and other symptoms, such as nerve palsy (e.g. foot drop) or gingival lines. This patient&#8217;s symptoms suggest pancytopenia rather than pure anemia. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Bernard-Soulier syndrome:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This syndrome describes a defect in the ability of platelets to adhere to von Willebrand factor. This can impair platelet aggregation and present as bleeding, but it would not explain this patient&#8217;s signs and symptoms of anemia (i.e. fatigue and shortness of breath with exertion) and leukopenia (i.e. frequent infections and poor wound healing). &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 65-year-old woman presents to the hematology/oncology clinic as a referral for abnormal blood counts. Over the past year, the patient has become more fatigued and short of breath with exertion and has noticed easy bruising. She was hospitalized twice for bacterial pneumonia in the past year. The patient does not use tobacco, alcohol, or recreational drugs. She works in a rubber production factory. Vital signs are unremarkable. On physical examination, she is pale with conjunctival pallor and scattered petechiae on the arms and legs. Serum complete blood count shows white blood cells 3200/mm<sup>3</sup>, hemoglobin 7.9 g/dL, platelets 45,000/mm<sup>3</sup> and 5% blasts on peripheral smear. Bone marrow biopsy is performed and shows over 10% dysplastic cells in all three cell lines and 12% blasts. Which of the following is the most likely diagnosis? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Myelodysplastic syndrome (MDS) with increased blasts"
        },
        {
          "id": 2,
          "text": "Acute promyelocytic leukemia (APML)"
        },
        {
          "id": 3,
          "text": "Acute myeloid leukemia (AML)"
        },
        {
          "id": 4,
          "text": "Myelodysplastic syndrome (MDS) with low blasts"
        },
        {
          "id": 5,
          "text": "Hypoplastic myelodysplastic syndrome (MDS)"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient presents to the hematology/oncology clinic with fatigue, shortness of breath with exertion, recurrent infections, and easy bruising. Complete blood count shows <strong>pancytopenia</strong>. This patient also works in a rubber factory, which could expose her to <strong>benzene</strong>, increasing her risk of developing MDS. This patient&#8217;s exposure and pancytopenia make <strong>myelodysplastic syndrome (MDS)</strong> likely. The abnormal morphology of all cell lines with &gt; 10% dysplastic cells and blast percentage of 12% on bone marrow biopsy indicates <strong>MDS with increased blasts</strong>.<br><br><strong>MDS</strong> refers to a group of hematologic malignancies characterized by impaired hematopoiesis. All three cell lines (white blood cells, red blood cells, platelets) can be affected and may have abnormal morphology, abnormal function, or abnormal numbers (<strong>cytopenias</strong>). Common risk factors include <strong>environmental exposure</strong> (e.g. benzene), prior chemotherapy, and prior radiation therapy. Patients generally <strong>present with signs of a cytopenia</strong>, which can be confirmed with a complete blood count. The diagnosis should be confirmed with peripheral smear and bone marrow biopsy.<br><br>Peripheral smear and bone marrow biopsy should be examined for <strong>dysplasia in one or more cell lines</strong> and for <strong>blasts</strong>. If there are dysplastic cells and <strong>&gt; 20% blasts on bone marrow biopsy, acute leukemia</strong> is diagnosed. If there is dysplasia in one or more lineages with <strong>dysplastic cells &gt; 10% and &lt; 20% blasts in the bone marrow</strong>, then <strong>MDS</strong> can be diagnosed. The bone marrow biopsy specimen should be sent for cytogenetic and molecular testing for <strong>MDS-defining genetic abnormalities</strong>, such as 5q deletion, SF3B1 mutation, and biallelic TP53 inactivation. If no defining genetic abnormalities are present, then the MDS is classified based on <strong>cellularity</strong> and the <strong>percentage of blasts</strong>. <strong>Hypoplastic MDS</strong> is defined by marked hypocellularity. <strong>MDS with low blasts</strong> is diagnosed when there are <strong>&lt; 5% blasts on bone marrow</strong> and <strong>&lt; 2% blasts on peripheral blood smear</strong>. <strong>MDS with increased blasts</strong> is diagnosed when there are <strong>5&#8210;19% blasts on bone</strong> <strong>marrow </strong>and <strong>&gt; 2% blasts on peripheral blood smear</strong>. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Myelodysplastic syndrome (MDS) with increased blasts:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Acute promyelocytic leukemia (APML):</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: APML is a specific subtype of acute myeloid leukemia (AML), which is usually treated with all-trans retinoic acid and arsenic trioxide or chemotherapy. This diagnosis requires &gt; 20% blasts on bone marrow examination. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Acute myeloid leukemia (AML):</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: The diagnosis of acute myeloid leukemia requires &gt; 20% blasts on bone marrow examination. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Myelodysplastic syndrome (MDS) with low blasts:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: MDS with low blasts is diagnosed when there is dysplasia in one or more cell lineages with &gt; 10% dysplastic cells, &lt; 5% blasts on bone marrow examination, and &lt; 2% blasts on peripheral blood smear. This patient has 12% blasts on bone marrow examination and 5% blasts on peripheral smear and, therefore, does not meet criteria for this diagnosis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Hypoplastic myelodysplastic syndrome (MDS):</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Hypoplastic MDS is characterized by a bone marrow examination showing marked hypocellularity. However, this patient&#8217;s bone marrow examination reveals 12% blasts, ruling out this diagnosis. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "<span>A 67-year-old woman presents to the hematology clinic with complaints of progressive fatigue, early satiety, and discomfort in the left upper abdomen. She has been experiencing night sweats and unexplained weight loss over the last few months. Her past medical history is significant for coronary artery disease, hypertension, and type 2 diabetes mellitus which are all well controlled with medications. Vital signs are within normal limits. There is marked splenomegaly on abdominal examination. Laboratory results are shown below. An attempt to perform a&#160;</span><span>bone marrow biopsy results</span><span>&#160;in the inability to aspirate bone marrow fluid despite several attempts. Which of the following is most likely to be seen on this patient&#8217;s peripheral blood smear?</span>&#160;<br><br><table><tbody><tr><td><strong>&#160;<span>Laboratory value</span></strong>&#160; &#160;&#160;</td><td><strong>&#160;<span>Result</span>&#160; &#160;&#160;</strong></td></tr><tr><td><strong>&#160;<span>Serum chemistries</span>&#160; &#160;&#160;</strong></td><td>&#160; &#160; &#160;</td></tr><tr><td>&#160;<span>Hemoglobin</span>&#160; &#160;&#160;</td><td>&#160;<span>9.1 g/dL</span>&#160; &#160;&#160;</td></tr><tr><td>&#160;<span>Hematocrit</span>&#160; &#160;&#160;</td><td>&#160;<span>27 %</span>&#160; &#160;&#160;</td></tr><tr><td>&#160;<span>Leukocyte count</span>&#160; &#160;&#160;</td><td>&#160;<span>3,100 /mm</span><span>3</span>&#160; &#160;&#160;</td></tr><tr><td>&#160;<span>Platelet count</span>&#160; &#160;&#160;</td><td>&#160;<span>105,000 /mm</span><span>3</span>&#160; &#160;&#160;</td></tr><tr><td>&#160;<span><em>JAK2</em></span><span>&#160;mutation</span>&#160; &#160;&#160;</td><td>&#160;<span>Positive</span>&#160; &#160;&#160;</td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br>",
      "choices": [
        {
          "id": 1,
          "text": "Hypersegmented neutrophils"
        },
        {
          "id": 2,
          "text": "Dacrocytes"
        },
        {
          "id": 3,
          "text": "Spherocytes"
        },
        {
          "id": 4,
          "text": "Schistocytes"
        },
        {
          "id": 5,
          "text": "Basophilic stippling"
        }
      ],
      "correct_choice_id": 2,
      "solution": "This patient's symptoms, <strong>splenomegaly</strong>, laboratory results (anemia, thrombocytopenia), and<strong>&#160;</strong><strong>dry tap</strong> on bone marrow biopsy are suggestive of <strong>primary myelofibrosis.</strong> Primary myelofibrosis is a myeloproliferative neoplasm characterized by bone marrow fibrosis and subsequent extramedullary hematopoiesis (notably in the spleen, causing splenomegaly). Myelofibrosis is associated with <strong>teardrop-shaped red blood cells</strong> or&#160;<strong>dacrocytes&#160;</strong>on the peripheral smear.&#160; &#160; &#160; &#160; <br><br>Primary myelofibrosis is characterized by fibrosis of the bone marrow due to abnormal <strong>megakaryocytes&#160;</strong>releasing growth factors, leading to ineffective erythropoiesis and anemia. The levels of white blood cells and platelets can vary. Cell counts may initially be elevated, but typically decrease with disease progression. Extramedullary hematopoiesis occurs, resulting in the <strong>production of blood cells in the liver and spleen,&#160;</strong>and the presence of <strong>dacrocytes </strong>(teardrop-shaped red blood cells) on a peripheral smear indicative of erythrocyte deformation. Genetic mutations such as JAK2, CALR, and MPL are common, and the difficulty in aspirating bone marrow, leading to a \"dry\" tap, further supports the diagnosis of primary myelofibrosis. &#160; &#160; &#160; &#160;<br><br>Patients with primary myelofibrosis and essential thrombocythemia can test positive for<strong> JAK2, CALR, or MPL</strong>. Patients with polycythemia vera will test positive for JAK2 mutation and negative for CALR and MPL. Patients with chronic myeloid leukemia have a Philadelphia Chromosome (PC) positive myeloproliferative neoplasm and will test positive for the <strong>BCR-ABL1 fusion gene (Philadelphia chromosome). &#160; </strong><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Hypersegmented neutrophils:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong><strong>:</strong>&#160;Hypersegmented&#160;neutrophils are typically associated with megaloblastic anemias, such as vitamin B12 or folate deficiency, not myelofibrosis which is the cause of anemia in this case.&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Dacrocytes:</strong><br><span style='opacity:0.9'><strong>Correct</strong><strong>: </strong>See Main Explanation.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Spherocytes:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong><strong>:</strong> Spherocytes are commonly seen in patients with hereditary spherocytosis or hemolytic&#160;anemias. Spherocytes are not typically seen in myelofibrosis.&#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Schistocytes:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong><strong>:</strong> Schistocytes are fragmented red blood cells often seen in microangiopathic hemolytic anemias, such as thrombotic thrombocytopenic purpura (TTP) or hemolytic-uremic syndrome (HUS), not typically in patients with myelofibrosis.</span></div><div style='margin-bottom: 12px;'><strong>❌ Basophilic stippling:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong><strong>: </strong>Basophilic stippling is typically seen in conditions associated with impaired hemoglobin synthesis, such as lead poisoning or thalassemia. They are not characteristic of primary myelofibrosis.&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 68-year-old woman presents to the emergency department with two days of dizziness, weakness and fatigue, and shortness of breath. Over the past week, the patient has also noticed easy bruising and bleeding while brushing her teeth. She has not had epistaxis, hematuria, hematochezia, or melena. Her past medical history is significant for lung cancer, which was treated fifteen years ago with chemotherapy and radiation. The patient does not currently take any medications. Temperature is 37.6&#186;C (99.7&#186;F), pulse is 108/min, respiratory rate is 18/min, blood pressure is 85/62 mmHg, and SpO<sub>2</sub> is 100% on room air. On physical examination, there is conjunctival pallor. There are diffuse scattered petechiae and small ecchymoses on skin examination. Chest radiograph shows no acute abnormalities. Serum complete blood count shows white blood cells 2300/mm<sup>3</sup> (50% neutrophils), hemoglobin 6.8 g/dL, and platelets 18,000/mm<sup>3</sup>. Which of the following is the best next step in management? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Transfusion of packed red blood cells"
        },
        {
          "id": 2,
          "text": "Bone marrow biopsy"
        },
        {
          "id": 3,
          "text": "Transfusion of pooled platelets"
        },
        {
          "id": 4,
          "text": "Prophylactic ceftriaxone"
        },
        {
          "id": 5,
          "text": "Intravenous vasopressors"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient who presents with dizziness, shortness of breath, weakness, fatigue, and easy bruising is found to have <strong>severe pancytopenia</strong>. Patients aged 60 and older, especially those at increased risk (i.e. prior benzene, chemotherapy, or radiation), who present with pancytopenia should be evaluated for <strong>myelodysplastic syndrome</strong>. This patient who likely has myelodysplastic syndrome and is <strong>hypotensive&#160;</strong>with a <strong>hemoglobin &lt; 7 g/dL</strong> should have <strong>transfusion of packed red blood cells</strong> and intravenous fluids.<br><br><strong>Myelodysplastic syndrome (MDS)</strong> refers to a group of hematologic malignancies characterized by <strong>impaired hematopoiesis</strong>. All three cell lines (white blood cells, red blood cells, platelets) can be affected, which may manifest as abnormal morphology, abnormal function, or abnormal numbers (<strong>cytopenias</strong>). Common risk factors include <strong>environmental exposures</strong> (e.g. benzene), <strong>prior chemotherapy</strong>, and <strong>prior radiation therapy</strong>. Patients typically <strong>present with signs or symptoms of cytopenias</strong>, which may include anemia (e.g. fatigue, exertional shortness of breath), leukopenia (recurrent infections, poor wound healing), and thrombocytopenia (e.g. easy bruising, bleeding, petechiae).<br><br>When MDS is suspected, other causes of cytopenia should first be ruled out. If clinical suspicion remains high for MDS, then a <strong>peripheral blood smear&#160;</strong>and <strong>bone marrow biopsy (aspiration)</strong> should be performed. If MDS is confirmed, further cytogenetic and molecular testing should be performed to determine the best treatment. Patients presenting <strong>acutely&#160;</strong>with <strong>signs of anemia&#160;</strong>should receive <strong>transfusion of blood products</strong> if hemoglobin is &lt; 7 g/dL. Patients should receive transfusion of platelets if the platelet count is less than 10,000/mm<sup>3</sup> or if there are signs of active bleeding. Patients with MDS have a <strong>high risk of infection</strong>, so clinical suspicion and evaluation for infection is an important part of treatment. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Transfusion of packed red blood cells:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Bone marrow biopsy:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: While a bone marrow biopsy will be necessary to evaluate the pancytopenia, acute management should come first. This patient with hypotension and a hemoglobin below 7 g/dL should receive a unit of packed red blood cells as well as intravenous fluids. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Transfusion of pooled platelets:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Although this patient is thrombocytopenic, transfusion of platelets is usually reserved for a platelet count less than 10,000/mm<sup>3</sup> unless patients are actively bleeding or undergoing procedures. This patient has no signs of active bleeding. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Prophylactic ceftriaxone:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This patient with pancytopenia and prior exposure to chemotherapy and radiation most likely has myelodysplastic syndrome. While myelodysplastic syndrome can increase the risk of infection, she does not have severe neutropenia warranting prophylactic antibiotics, and ceftriaxone would not be an appropriate choice for prophylactic coverage. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Intravenous vasopressors:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This patient is hypotensive but has not yet received intravenous fluids or blood products. If she remains hypotensive after transfusion and fluid resuscitation, vasopressors would be appropriate. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A graduate student is conducting research on pancreatic physiology. For one of their experiments, a culture flask containing pancreatic beta cells is prepared. Afterward, glucose is added to the flask. The intracellular ATP/ADP ratio, magnitude of the outflowing potassium current, and magnitude of the inflowing calcium current are measured. Which of the following sets of findings will most likely be observed?",
      "choices": [
        {
          "id": 1,
          "text": "&#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8595;&#160;&#160;&#8593;&#160;&#160;&#8593;&#160;"
        },
        {
          "id": 2,
          "text": "&#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8595;&#160;&#160;&#8595;&#160;&#8593;&#160;"
        },
        {
          "id": 3,
          "text": "&#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8593;&#160;&#160;&#8593;&#160;&#160;&#8593;&#160;"
        },
        {
          "id": 4,
          "text": "&#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8593;&#160;&#160;&#8595;&#160;&#160;&#8593;&#160;"
        },
        {
          "id": 5,
          "text": "&#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8593;&#160;&#160;&#8595;&#160;&#8595;"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<strong>Insulin&#160;</strong>is a type of peptide hormone that reduces the amount of glucose in the blood. It is produced in <strong>pancreatic beta cells.</strong> Insulin&#8217;s main function is to facilitate the transport of glucose from the blood into the various insulin-responsive tissues like muscle cells and adipose tissue. &#160; <br><br>Insulin is released from beta cells via a four-step process. First, extracellular glucose is transported into beta cells via <strong>GLUT2 receptors.</strong> Second, inside the cell, glucose undergoes glycolysis to <strong>produce ATP</strong>. Third, the ATP binds to and <strong>closes potassium channels.</strong> This causes a decrease in the outflowing potassium current, resulting in cellular depolarization. Fourth, depolarization <strong>opens voltage-gated calcium channels,</strong> which increases intracellular calcium and causes insulin secretion. &#160; <br><br>Once released, insulin binds to its receptors in the target tissue (e.g., adipose, liver, muscle) and causes intracellular storage vesicles, which contain glucose transport proteins called GLUT4, to fuse with the cellular membrane. The<strong>&#160;GLUT4</strong> proteins then embed themselves into the membrane and allow glucose to enter the cell, ultimately reducing blood glucose levels. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ &#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8595;&#160;&#160;&#8593;&#160;&#160;&#8593;&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>In this experiment, glucose is administered to beta cells. The elevated glucose would lead to increased glycolysis and an elevated ATP/ADP ratio. The newly synthesized ATP then closes potassium channels, resulting in a decrease in the magnitude of the outflowing potassium current.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ &#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8595;&#160;&#160;&#8595;&#160;&#8593;&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Increased glucose concentrations would result in increased glycolysis, resulting in an elevated ATP/ADP ratio.</span></div><div style='margin-bottom: 12px;'><strong>❌ &#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8593;&#160;&#160;&#8593;&#160;&#160;&#8593;&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Increased glucose concentrations would result in increased glycolysis, resulting in an elevated ATP/ADP ratio. However, the ATP then closes potassium channels, which decreases the outflowing potassium current.</span></div><div style='margin-bottom: 12px;'><strong>✅ &#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8593;&#160;&#160;&#8595;&#160;&#160;&#8593;&#160;:</strong><br><span style='opacity:0.9'><strong>Correct: </strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ &#160;ATP/ADP Ratio&#160;&#160;Potassium Current Magnitude&#160;&#160;Calcium Current Magnitude&#160;&#160;&#8593;&#160;&#160;&#8595;&#160;&#8595;:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>An increase in extracellular glucose concentration leads to an increased ATP/ADP ratio and a decrease in the magnitude of the outflowing potassium current. The latter depolarizes the beta cell and causes voltage-gated calcium channels to open, resulting in an increase in the magnitude of the inflowing calcium current.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "<span>A 1</span><span>4</span><span>-year-old&#160;</span><span>boy&#160;</span><span>presents to&#160;</span><span>the clinic</span><span>&#160;</span><span>with concerns&#160;</span><span>regarding</span><span>&#160;delayed sexual development. The patient states that&#160;</span><span>his genitals look different&#160;</span><span>from</span><span>&#160;his peers</span><span>&#160;when he changes in gym&#160;</span><span>class,</span><span>&#160;and</span><span>&#160;</span><span>h</span><span>e</span><span>&#160;is shorter than the rest of his class</span><span>.</span><span>&#160;There is no history of headaches, visual&#160;</span><span>disturbances,</span><span>&#160;or neurological deficits.</span><span>&#160;</span><span>His&#160;</span><span>parent</span><span>&#160;</span><span>reports</span><span>&#160;</span><span>that&#160;</span><span>when he was growing&#160;</span><span>up,</span><span>&#160;he</span><span>&#160;was short&#160;</span><span>until&#160;</span><span>the age of 17 years</span><span>&#160;</span><span>when he had a growth spurt associated with the development of</span><span>&#160;pubic hair and a deepened voice</span><span>.</span><span>&#160;</span><span>Past medical and surgical history are&#160;</span><span>noncontributory</span><span>.</span><span>&#160;</span><span>Temperature is 37<strong>&#176;</strong>C (98.6<strong>&#176;</strong>F), pulse is&#160;</span><span>86</span><span>/min, respirations are&#160;</span><span>19</span><span>/min,&#160;</span><span>and&#160;</span><span>blood pressure is&#160;</span><span>120</span><span>/</span><span>75</span><span>&#160;mm</span><span>&#160;Hg</span><span>. Growth charts&#160;</span><span>show his height consistently at the 3</span><span><sup>rd</sup></span><span>&#160;</span><span>per</span><span>centile since the age of 2 and his weight at the 25</span><span><sup>th</sup></span><span>&#160;</span><span>per</span><span>centile</span><span>.</span><span>&#160;</span><span>On p</span><span>hysical</span><span>&#160;examination, th</span><span>ere is no&#160;</span><span>pubic hair</span><span>, no gynecomastia</span><span>,</span><span>&#160;and&#160;</span><span>testicular volume is 3&#160;</span><span>mL</span><span>.</span><span>&#160;</span><span>Luteinizing</span><span>&#160;hormone (LH)</span><span>,&#160;</span><span>follicle</span><span>-</span><span>stimulating</span><span>&#160;hormone</span><span>&#160;(</span><span>FSH</span><span>)</span><span>,&#160;</span><span>and&#160;</span><span>testosterone levels are low</span><span>.</span><span>&#160;Thyroid and prolactin levels are normal. X-ray of the left</span><span>-</span><span>hand shows h</span><span>is</span><span>&#160;bone age&#160;</span><span>consistent with</span><span>&#160;11 years</span><span>&#160;of age.</span><span>&#160;</span><span>Which of the following&#160;</span><span>is the&#160;</span><span>most likely</span><span>&#160;underlying</span><span>&#160;cause of</span><span>&#160;delayed sexual&#160;</span><span>development</span><span>&#160;in this patient?</span><span>&#160;</span>&#160;",
      "choices": [
        {
          "id": 1,
          "text": "Central nervous system&#160;(CNS)&#160;tumor&#160;&#160;"
        },
        {
          "id": 2,
          "text": "Constitutional delay&#160;"
        },
        {
          "id": 3,
          "text": "Hyperprolactinemia&#160;"
        },
        {
          "id": 4,
          "text": "Genetic syndrome&#160;"
        },
        {
          "id": 5,
          "text": "Radiation exposure &#160;&#160;"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/RySluJCiRoeZQftlziB0CxnnS-WmAQFQ/_.png\"></div><br>This patient&#160;presents&#160;with&#160;<strong>delayed puberty</strong>&#160;and a&#160;<strong>family history</strong>&#160;that is positive&#160;for delayed puberty.&#160;He has no&#160;history&#160;of&#160;chronic disease or&#160;chronic&#160;stress,&#160;and he has no neurologic signs or&#160;symptoms. He&#160;is found to have&#160;<strong>delayed bone age on radiographs</strong>.&#160;<strong>Constitutional delay of growth and puberty (CDGP)</strong>&#160;<span>is the most&#160;</span>probable cause<span>&#160;of&#160;</span>these f<span>indings</span>.<br><br>Constitutional delay of growth and puberty (CDGP)&#160;is&#160;the most&#160;common&#160;cause of delayed puberty and is considered a&#160;<strong><span>normal variant</span>.</strong> It&#160;is due to a transient functional defect in production of&#160;GnRH&#160;from the hypothalamus secondary to genetic factors and results&#160;in&#160;<strong>puberty beginning later than the typical age</strong>,&#160;but&#160;puberty&#160;then&#160;progressing&#160;normally afterward.&#160;An affected child typically presents in early adolescence, when peers are beginning to develop and have&#160;growth spurts, but the patient is not. The patient's&#160;<strong>height is typically at or below the 3<sup>rd</sup> percentile</strong>&#160;for age.&#160;<strong>Family history of delayed puberty</strong>&#160;in a parent&#160;or&#160;the presence of&#160;&#8220;late bloomers&#8221;&#160;in the family&#160;is positive in 50% of the patients.&#160;The physical examination findings may reveal delayed&#160;adrenarche&#160;and&#160;gonadarche&#160;but are otherwise unremarkable.&#160;Pubertal delay can lead to significant psychosocial distress in teens and their families.&#160;Without intervention, final adult height usually reaches or approximates the target height range.<br><br>The diagnosis of CDPG starts with&#160;taking a&#160;focused history&#160;including the&#160;<strong>growth and pubertal trends of the family members</strong>.&#160;Physical examination&#160;should assess&#160;<strong>testicular volume and Tanner stage</strong>.&#160;Initial investigations include&#160;<strong>luteinizing hormone, follicle-stimulating hormone, testosterone, estradiol, thyroid studies, prolactin</strong>,&#160;and&#160;<strong>radiological imaging</strong>&#160;for bone age&#160;should be ordered.&#160;The absence&#160;of chronic&#160;disease, excessive stress,&#160;and&#160;neurological signs&#160;and&#160;symptoms,&#160;and&#160;the presence of&#160;<strong>prepubertal levels</strong>&#160;of&#160;gonadotropins and&#160;sex hormones&#160;with normal thyroid and prolactin&#160;levels,&#160;<strong>delayed bone age</strong>,&#160;and&#160;positive family history&#160;can be used to make&#160;the diagnosis&#160;of CDPG.&#160; &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Central nervous system&#160;(CNS)&#160;tumor&#160;&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: CNS tumors like pituitary adenomas can lead to delayed puberty and patients typically present with headaches, visual disturbances, prepubertal gonadotropins and sex hormones, and delayed bone age. This patient has no history of neurological deficits or symptoms of a CNS tumor. This patient&#8217;s personal and family history of delayed puberty is more suggestive of constitutional delay.&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Constitutional delay&#160;:</strong><br><span style='opacity:0.9'><strong>Correct</strong>:&#160;See Main Explanation.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Hyperprolactinemia&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>:&#160;Hyperprolactinemia typically caused by&#160;pituitary&#160;adenoma can lead to delayed puberty, gynecomastia, nipple discharge,&#160;and CNS symptoms not noted in this patient.&#160;This patient&#8217;s personal and family history of delayed puberty is more suggestive of constitutional delay.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Genetic syndrome&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>:&#160;Genetic syndromes can lead to delayed&#160;puberty;&#160;Patients with Kleinfelter syndrome tend to be&#160;tall&#160;in&#160;stature&#160;and patients with&#160;Kalman syndrome&#160;often have associated anosmia.&#160;This patient&#8217;s&#160;personal and family&#160;history&#160;of delayed puberty&#160;is more suggestive of constitutional delay.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Radiation exposure &#160;&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Radiation exposure can lead to delayed puberty secondary to acquired hypergonadotropic hypogonadism. This patient has no history of radiation exposure, making this an unlikely cause of his pubertal delay. This patient&#8217;s personal and family history of delayed puberty is more suggestive of constitutional delay.&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A group of researchers are studying the metabolic effects of alcohol use disorder and the associated electrolyte abnormalities. Which of the following combinations is most likely to be present in an individual with severe alcohol use disorder? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Normal magnesium, increase PTH &#160;"
        },
        {
          "id": 2,
          "text": "Moderate hypomagnesemia, decrease PTH &#160;"
        },
        {
          "id": 3,
          "text": "Severe hypomagnesemia, decrease PTH &#160;"
        },
        {
          "id": 4,
          "text": "Normal magnesium, normal PTH &#160;"
        },
        {
          "id": 5,
          "text": "Severe hypomagnesemia, increase PTH &#160;"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<strong>Severe magnesium depletion</strong> (usually &lt;1.2 mg/dL), such as that seen with alcohol use disorder, can result in hypocalcemia, which is due to the <strong>suppressive effect</strong> of hypomagnesemia on <strong>parathyroid secretion</strong> as well as <strong>skeletal resistance to parathyroid hormone (PTH). &#160;&#160;</strong><br><br>On the contrary, <strong>moderate hypomagnesemia</strong> promotes the action of PTH on kidneys to improve magnesium reabsorption. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Normal magnesium, increase PTH &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This answer choice is incorrect. Alcohol use disorder would result in severe hypomagnesemia, leading to the inhibition of PTH release. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Moderate hypomagnesemia, decrease PTH &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Moderate hypomagnesemia stimulates the release of PTH. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Severe hypomagnesemia, decrease PTH &#160;:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Normal magnesium, normal PTH &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This answer choice is incorrect. Alcohol use disorder would result in severe hypomagnesemia, leading to the inhibition of PTH release. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Severe hypomagnesemia, increase PTH &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Severe hypomagnesemia inhibits the release of PTH. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 17-year-old girl presents to the physician for evaluation of a neck mass. She first noticed the mass five weeks ago, following an upper respiratory infection. She has not experienced any dyspnea or dysphagia. Past medical history is unremarkable. Temperature is 37.5&#176;C (99.5&#176;F), blood pressure is 109/72 mmHg, and pulse is 68/min. On physical examination, a midline mass is observed over the anterior neck around 1 centimeter below the hyoid bone. The mass is soft and nontender to palpation. The mass moves when the patient swallows. Which of the following best describes the underlying cause of this patient&#8217;s condition? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Granulomatous thyroid gland inflammation"
        },
        {
          "id": 2,
          "text": "Incomplete obliteration of the thyroglossal duct"
        },
        {
          "id": 3,
          "text": "Outpouching of the cervical esophagus"
        },
        {
          "id": 4,
          "text": "Failed obliteration of a branchial cleft"
        },
        {
          "id": 5,
          "text": "Malignant proliferation of thyrocytes"
        }
      ],
      "correct_choice_id": 2,
      "solution": "This patient has a painless, midline neck mass that moves with swallowing. These findings suggest a <strong>thyroglossal duct cyst</strong>, an embryologic remnant that forms when the thyroglossal duct fails to close after birth. &#160;<br><br>During embryological development, the thyroid gland originates in the floor of the embryonic pharynx in an area called the <strong>foramen cecum</strong>, found on the dorsum of the tongue. The thyroid gland subsequently migrates from the tongue into the neck, passing anterior to the hyoid bone through the <strong>thyroglossal duct</strong>. This duct normally disappears after birth; however, in some cases, <strong>part of this duct remains,</strong> and a thyroglossal duct cyst can develop. &#160;<br><br>Thyroglossal duct cysts are typically located along the <strong>anterior midline portion</strong> of the neck. They can form a visual and palpable mass. The cysts <strong>move&#160;</strong><strong>with swallowing</strong> or tongue movement, which can help distinguish them from other neck masses (e.g. malignant tumors). Most cases are <strong>asymptomatic</strong>, but some can cause <strong>neck pain</strong> or <strong>dysphagia&#160;</strong>if they grow large or become <strong>infected</strong>. In rare cases, a <strong>thyroglossal duct cyst carcinoma</strong> can develop from ectopic thyroid tissue within the cyst. Other complications may include infections, rupture, and formation of a thyroglossal fistula. &#160;<br><br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/aKzF3yr1QD_JGtuYGA0duJxaQ4_pl-Tp/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Granulomatous thyroid gland inflammation:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>This answer choice describes subacute granulomatous thyroiditis, also called de Quervain thyroiditis. The condition typically presents as a painful swelling of the thyroid gland following an upper respiratory infection. In contrast, this patient&#8217;s mass is painless.</span></div><div style='margin-bottom: 12px;'><strong>✅ Incomplete obliteration of the thyroglossal duct:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Outpouching of the cervical esophagus:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>A Zenker diverticulum is characterized by outpouching of the esophageal mucosa through an area of muscle weakness in the posterior esophageal wall. The condition most commonly develops at Killian&#8217;s triangle and involves the cervical esophagus. The condition can present with dysphagia, regurgitation, cough, aspiration, and foul-smelling breath. However, it would not typically present as an anterior neck mass.</span></div><div style='margin-bottom: 12px;'><strong>❌ Failed obliteration of a branchial cleft:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>This answer choice describes a branchial cleft cyst. The condition typically presents as a nontender, lateral neck mass. In contrast, this patient has a midline neck mass that moves when she swallows, suggesting a thyroglossal duct cyst. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Malignant proliferation of thyrocytes:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Thyroid cancer is characterized by malignant proliferation of thyroid gland tissue. The condition presents as a firm and usually painless nodule. If the cancer invades surrounding tissue, the tumor can remain fixed and will not move with swallowing or tongue movements. In contrast, this patient has a soft and mobile neck mass, which suggests a thyroglossal duct cyst.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 44-year-old female presents to an endocrinologist for follow-up testing after having findings concerning for an endocrine disorder at her primary care physician's office. She initially presented with several months of fatigue, weight loss, and abdominal pain. Her laboratory findings from this visit are demonstrated below:<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/sCyW3ROxRKaIUHieIpVnlp0nQJaCPk9U/_.png\"></div><br><br>Which of the following tests will help to further define the etiology of this patient&#8217;s clinical presentation? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "ACTH stimulation test"
        },
        {
          "id": 2,
          "text": "Metyrapone stimulation test"
        },
        {
          "id": 3,
          "text": "CRH stimulation test &#160;"
        },
        {
          "id": 4,
          "text": "Plasma renin activity"
        },
        {
          "id": 5,
          "text": "Dexamethasone suppression test"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/Wj92utafQxOZfaNRjX7QZF7pTBeya4kI/_.png\"></div><br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/mVabJYXlT5SkJZfv3CP70k22TtWmKpPf/_.png\"></div><br><br>This patient presents with symptoms consistent with adrenal insufficiency and has laboratory findings concerning for secondary or tertiary adrenal insufficiency. The best test to confirm this diagnosis is the <strong>ACTH stimulation test</strong>, also referred to as the <strong>Cortrosyn stimulation test</strong>. &#160; <br><br>The diagnosis of adrenal insufficiency begins by <strong>first measuring a morning or random cortisol level</strong>. If low, a diagnosis of adrenal insufficiency is established. If equivocal, a metyrapone stimulation test can be performed to confirm the presence of adrenal insufficiency. &#160; <br><br>After a low cortisol level is established, the next step is <strong>measurement of basal adrenocorticotropic hormone (ACTH)</strong>. If ACTH is high, then the patient&#8217;s symptoms are due to primary adrenal insufficiency. If ACTH is low, then the adrenal insufficiency is either due to pituitary dysfunction (secondary adrenal insufficiency) or hypothalamic dysfunction (tertiary adrenal insufficiency). The differentiation between primary and secondary/tertiary adrenal insufficiency can be confirmed via the <strong>adrenocorticotropic hormone (ACTH) stimulation test</strong>, which measures cortisol levels before and after administration of exogenous ACTH. If primary, exogenous ACTH administration will not yield an increase in cortisol, whereas in secondary/tertiary adrenal insufficiency, cortisol levels will rise. &#160; <br><br>A <strong>corticotropin-releasing hormone (CRH) stimulation test</strong> can then differentiate between secondary and tertiary adrenal insufficiency. In secondary adrenal insufficiency, which arises due to pituitary dysfunction, exogenous CRH will not yield a subsequent increase in ACTH. In contrast, exogenous CRH will yield an increase in ACTH in the setting of tertiary adrenal insufficiency, which arises when the hypothalamus is not producing adequate CRH. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ ACTH stimulation test:</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Metyrapone stimulation test:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>The metyrapone stimulation test is utilized in the setting of an indeterminate cortisol study. In contrast, this patient has low morning cortisol levels, which makes the metyrapone stimulation test not useful.</span></div><div style='margin-bottom: 12px;'><strong>❌ CRH stimulation test &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> The corticotropin-releasing hormone (CRH) stimulation test involves administering exogenous CRH and monitoring for a change in levels ACTH. It is used to determine whether a patient has secondary or tertiary adrenal insufficiency and gets performed after an ACTH stimulation test, which is also termed the Cortrosyn stimulation test.</span></div><div style='margin-bottom: 12px;'><strong>❌ Plasma renin activity:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Measurement of plasma renin activity is useful in the confirmation of primary adrenal insufficiency. This patient has low levels of AM cortisol and ACTH, which is reflective of either secondary or tertiary adrenal insufficiency.</span></div><div style='margin-bottom: 12px;'><strong>❌ Dexamethasone suppression test:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>The dexamethasone suppression test is utilized in the evaluation of Cushing disease, not adrenal insufficiency.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 76-year-old male presents to the emergency department with altered mental status. The patient was found down for an unknown period of time by neighbors. His initial blood sugar was 45 mg/dL, for which he was given dextrose prior to arrival. He is unable to provide any medical history due to his mental status. Temperature is 38.3&#176;C (101&#176;F), pulse is 110/min, respirations are 21/min, blood pressure is 84/62 mmHg, and oxygen saturation is 92% on room air. Physical examination is notable for a confused male in moderate respiratory distress with rales at the right lower lobe. The patient is given two liters of intravenous normal saline, acetaminophen, intravenous ceftriaxone and azithromycin, and norepinephrine without improvement in his vital signs or clinical status. A repeat blood sugar is 37 mg/dL, and initial laboratory findings are demonstrated below:<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/2Cy6MnSTQhu9eU8WnTai9_v4QNuH9OkQ/_.png\"></div><br><br>Which of the following medications is indicated for management of this patient's clinical presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Intravenous hydrocortisone"
        },
        {
          "id": 2,
          "text": "Intravenous fludrocortisone"
        },
        {
          "id": 3,
          "text": "Intravenous lactated ringers"
        },
        {
          "id": 4,
          "text": "Intravenous vancomycin"
        },
        {
          "id": 5,
          "text": "Intravenous type O negative blood"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient with an unknown medical history presents altered, febrile, and likely has underlying pneumonia. Additionally, he is persistently hypoglycemic and hypotensive despite multiple resuscitative measures, and his laboratory findings indicate hyponatremia and hyperkalemia. Together, his findings are consistent with adrenal crisis for which the appropriate treatment is <strong>intravenous hydrocortisone</strong>. &#160; <br><br><strong>Acute adrenal insufficiency</strong>, also termed adrenal crisis, refers to the acute loss of adrenal hormones aldosterone and cortisol. It is often precipitated in patients with chronic adrenal insufficiency who are exposed to physiologic stresses. Clinically, acute adrenal insufficiency is characterized by hypotension and <strong>refractory shock</strong> -- shock that does not respond to intravenous fluids, blood products, pressors, or antibiotics. Additional features are often dependent on the etiology but can include anorexia, nausea, vomiting, abdominal pain, weakness, fatigue, confusion, and coma. &#160; <br><br>There are many precipitating causes of acute adrenal insufficiency, including <strong>abdominal trauma</strong>, <strong>infections</strong>, and <strong>recent surgeries</strong>. In the emergency setting, acute adrenal insufficiency with hypotension should be treated with intravenous fluids and <strong>intravenous hydrocortisone</strong> due to its potent glucocorticoid effects on hemodynamics and glycemic control. &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/YgYuxhsBQVGGkZJXZQBK-mB6TbinvM2X/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Intravenous hydrocortisone:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Intravenous fludrocortisone:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>While fludrocortisone may assist in treating this patient&#8217;s adrenal crisis, it is primarily a mineralocorticoid, meaning that it will work by mitigating the effects of lost aldosterone. Fludrocortisone has weak glucocorticoid activity, and it will do little to reverse this patient's persistent hypoglycemia. As a result, hydrocortisone is the preferred first-line agent in treating acute adrenal insufficiency.</span></div><div style='margin-bottom: 12px;'><strong>❌ Intravenous lactated ringers:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>This patient has already been resuscitated with two liters of normal saline without improvement in blood pressure. Administrating additional intravenous fluids will be unlikely to improve his condition.</span></div><div style='margin-bottom: 12px;'><strong>❌ Intravenous vancomycin:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> This patient is already being adequately covered for community acquired pneumonia with ceftriaxone and azithromycin. Vancomycin is not indicated in the treatment of this patient&#8217;s clinical condition.</span></div><div style='margin-bottom: 12px;'><strong>❌ Intravenous type O negative blood:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Blood transfusion is generally indicated for hemoglobin levels &lt;7g/dL. This patient is slightly anemic but not to the point of requiring blood transfusion.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 56-year-old female presents to her endocrinologist for follow-up testing after an MRI demonstrated a pituitary lesion. The patient initially presented with several months of fatigue, weight loss, and chronic headaches. During this visit, the patient has labs drawn, and the results are demonstrated below:<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/mB84JTeWRYK5ChLN_5kzzm_pTemSnDH4/_.png\"></div><br><br>Which of the following tests will help to further define the etiology of this patient&#8217;s clinical presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Metyrapone stimulation test"
        },
        {
          "id": 2,
          "text": "ACTH stimulation test"
        },
        {
          "id": 3,
          "text": "CRH stimulation test"
        },
        {
          "id": 4,
          "text": "Plasma renin activity"
        },
        {
          "id": 5,
          "text": "Dexamethasone suppression test"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/wuwAlPMjS7SAO5Thq-zAjOIDSX2_E6ue/_.png\"></div><br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/BZ3y1HZ-RKeNzROC0G7aklpCTxGIiqXz/_.png\"></div><br><br>This patient has chronic headaches, constitutional symptoms, and an MRI demonstrating a pituitary lesion. Her evaluation demonstrates a low ACTH level but an indeterminate cortisol level. When adrenal insufficiency is suspected but the measured cortisol level is inconclusive, the next step is to perform a <strong>metyrapone stimulation test</strong>. &#160; <br><br>The diagnosis of adrenal insufficiency begins by <strong>first measuring a morning or random cortisol level</strong>. If low, a diagnosis of adrenal insufficiency is established. If the cortisol level is equivocal or normal, but there is still suspicion for an adrenal disorder, a metyrapone stimulation test can be performed to further delineate the etiology of adrenal insufficiency. &#160; <br><br><strong>Metyrapone&#160;</strong>blocks cortisol biosynthesis by acting as a reversible <strong>inhibitor of 11&#946;-hydroxylase</strong>, which in turn prevents conversion of 11-deoxycortisol to cortisol. In healthy patients, metyrapone stimulates adrenocorticotropic hormone (ACTH) secretion and increases plasma 11-deoxycortisol levels. In patients with primary adrenal insufficiency, metyrapone will increase ACTH levels, since the hypothalamic-pituitary axis is intact, but it will not increase 11-deoxycortisol levels, since the adrenal gland itself is dysfunctional. In contrast, in patients with secondary or tertiary adrenal insufficiency, metyrapone will not cause an increase in ACTH or 11-deoxycortisol levels, since the hypothalamic-pituitary axis is not functioning properly. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Metyrapone stimulation test:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ ACTH stimulation test:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> The differentiation between primary and secondary/tertiary adrenal insufficiency can be made via the adrenocorticotropic hormone (ACTH) stimulation test, which is also called the Cortrosyn stimulation test. The test measures cortisol levels before and after administration of exogenous ACTH. It is only utilized when cortisol levels are definitive in establishing the diagnosis of adrenal insufficiency.</span></div><div style='margin-bottom: 12px;'><strong>❌ CRH stimulation test:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> The corticotropin-releasing hormone (CRH) stimulation test involves administering exogenous CRH and monitoring for a change in ACTH levels. It is used to differentiate whether a patient has secondary or tertiary adrenal insufficiency. The CRH stimulation test is generally performed after an ACTH stimulation test or cortisol level has established a definitive diagnosis of adrenal insufficiency. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Plasma renin activity:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Measurement of plasma renin activity is useful in the confirmation of primary adrenal insufficiency. This patient has low levels of ACTH, which is more concerning for secondary or tertiary adrenal insufficiency.</span></div><div style='margin-bottom: 12px;'><strong>❌ Dexamethasone suppression test:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> The dexamethasone suppression test is utilized in the evaluation of Cushing disease, not adrenal insufficiency.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 36-year-old woman comes to the office because of progressive muscle weakness and easy bruising. She reports difficulty climbing stairs and combing her hair and has noticed she has been gaining weight over the past six months. The patient&#8217;s menstrual cycle has been irregular for the past three months. Her past medical history is unremarkable, and she takes no medications. She consumes 2-3 beers on weekends and does not smoke or use illicit drugs. Her temperature is 37.0&#176;C (98.6&#176;F), pulse is 90/min, respirations are 16/min, and blood pressure is 160/100 mmHg. BMI is 33 kg/m<sup>2</sup>. Physical examination shows multiple ecchymoses on her extremities. Examination findings of the face are shown. No increase in serum ACTH is observed after intravenous administration of corticotropin-releasing hormone (CRH). If treated medically, which of the following best describes the mechanism of action of the first-line drug used to manage this patient&#8217;s condition?<br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/OB12rWfzRoW-Mwan3oKILScoTdGYELck/_.jpg\"></div><strong><sup>Reproduced from Flickr</sup></strong><br><br><table><tbody><tr><td><strong>Laboratory value</strong><br></td><td><strong>Results</strong><br></td></tr><tr><td><strong>Serum chemistry</strong><br></td><td><br></td></tr><tr><td>Serum sodium<br></td><td>146 mEq/ml<br></td></tr><tr><td>Serum potassium<br></td><td>3.4 mEq/ml<br></td></tr><tr><td>Serum glucose<br></td><td>210 mg/dL<br></td></tr><tr><td>Serum adrenocorticotropic hormone (ACTH)<br></td><td>2 pg/mL (normal: 6-20 pg/mL)<br></td></tr><tr><td><strong>Urine tests</strong><br></td><td><br></td></tr><tr><td>Urine beta-hCG<br></td><td>Negative<br></td></tr><tr><td>24-hour urinary cortisol<br></td><td>155 mcg/24hrs (normal: 3.5 and 45 mcg/24hrs)<br></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br>",
      "choices": [
        {
          "id": 1,
          "text": "Bacterial cell wall synthesis inhibitors"
        },
        {
          "id": 2,
          "text": "Fungal nucleic acid synthesis inhibitors"
        },
        {
          "id": 3,
          "text": "Adrenal hormone synthesis inhibitors"
        },
        {
          "id": 4,
          "text": "Glucocorticoid receptor antagonists"
        },
        {
          "id": 5,
          "text": "Dopamine agonists"
        }
      ],
      "correct_choice_id": 3,
      "solution": "This patient&#8217;s presentation with progressive <strong>proximal muscle weakness, weight gain,&#160;</strong>and <strong>menstrual irregularity</strong>, combined with <strong>facial plethora and acne</strong>, is suggestive of <strong>hypercortisolism</strong>. Laboratory findings of <strong>hyperglycemia</strong>, high 24-hour <strong>urinary cortisol levels</strong>, low serum ACTH levels, and no response to corticotropin-releasing hormone (CRH) stimulation are consistent with the diagnosis of <strong>ACTH-independent Cushing syndrome</strong>.<br><br>Cushing syndrome is a disorder with physical and mental changes resulting from chronic exposure to excessive cortisol in the blood (exogenous or endogenous). These patients usually present with weight gain, plethora, round face, menstrual changes, hypertension, and ecchymoses. Due to elevated cortisol levels, serum chemistry usually reveals <strong>hypernatremia, hypokalemia, and hyperglycemia</strong>. Diagnosis is based on <strong>24-hour urinary cortisol excretion, serum ACTH levels,&#160;</strong>and <strong>imaging</strong>.<br><br>Surgery, with the removal of the hyperplastic adrenal gland, is the primary treatment option. Still, when it is delayed or contraindicated, <strong>adrenal hormone synthesis inhibitors (AHSIs)</strong> are administered to control hypercortisolism by <strong>preventing steroidogenesis</strong>. Common AHSIs, their mechanism of action, side effects, and indications are listed below.<br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/UO2bn0-hRkakDdTkFoVQ8J4AQtmG-F6c/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Bacterial cell wall synthesis inhibitors:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Penicillins, cephalosporins, and vancomycin are important bacterial cell wall synthesis inhibitors used to treat various bacterial infections, including pneumonia, meningitis, and urinary tract infection. This patient&#8217;s presentation is most likely indicative of a chronic adrenal gland disorder, and antibacterials are not indicated in its management. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Fungal nucleic acid synthesis inhibitors:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Fungal nucleic acid synthesis inhibitors (e.g. flucytosine) inhibit DNA and RNA biosynthesis. They have no clinical significance in the treatment of Cushing syndrome. In contrast, ketoconazole and fluconazole are drugs that act by inhibiting fungal ergosterol synthesis, a component of the fungal cell membrane. Azole antifungals can be used in managing patients with Cushing syndrome since they inhibit several CYP enzymes in the adrenal glands resulting in a rapid and marked reduction in adrenal steroid production. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Adrenal hormone synthesis inhibitors:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Glucocorticoid receptor antagonists:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Mifepristone, an anti-progestational drug, can act as a glucocorticoid receptor antagonist at high doses. It is known to treat cortisol-induced hyperglycemia but is reserved as a second-line option in patients who have failed surgery or are not candidates for surgery. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Dopamine agonists:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Cabergoline is a dopamine agonist that has been shown to decrease 24-hour urinary cortisol levels in patients with Cushing disease, characterized by an ACTH-secreting pituitary tumor. This patient is most likely suffering from Cushing syndrome (given the results of the low-dose dexamethasone suppression test) and would not benefit from a dopamine agonist. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 33-year-old woman presents to the emergency department for the sudden onset of a severe headache associated with palpitations and sweating. She reports that similar episodes have been happening intermittently for the past few months. She has a past medical history of retinal angiomas and a family history of renal cancer in her mother which developed at a young age. Temperature is 36.8&#176;C (98.2&#176;F), blood pressure is 180/110 mm Hg, pulse is 122/min, respiratory rate is 18/min, and oxygen saturation is 97% on room air. Physical examination reveals a well-appearing woman in no apparent distress. Neurological examination reveals no focal deficits, and fundoscopic examination is significant for the presence of bilateral retinal angiomas. Laboratory evaluation including CBC and electrolytes is within normal limits. Which of the following is the best next step in the evaluation? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "24-hour urine collection for metanephrines, catecholamines, and metabolites"
        },
        {
          "id": 2,
          "text": "CT scan of the abdomen"
        },
        {
          "id": 3,
          "text": "CT scan of the head"
        },
        {
          "id": 4,
          "text": "Genetic testing for mutations in the VHL gene"
        },
        {
          "id": 5,
          "text": "Genetic testing for mutations in the NF1 gene"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/Ai2w_p0CSAumVyWCoqnUUmErT6u_aFQg/_.png\"></div><br>This patient presents with intermittent episodes of severe headache, palpitations, and sweating, along with elevated blood pressure, which are classic signs and symptoms of <strong>pheochromocytoma</strong>. The presence of <strong>retinal angiomas</strong> and a <strong>family history of renal cancer at a young age</strong> are indicative of <strong>von Hippel-Lindau (VHL) disease</strong>. VHL is an autosomal dominant disorder associated with the development of benign and malignant tumors, including pheochromocytomas.<br><br>The diagnostic workup for pheochromocytoma should begin with <strong>biochemical testing</strong> to <strong>confirm excessive catecholamine secretion</strong>. This can be done by measuring <strong>plasma fractionated metanephrines</strong> or by ordering <strong>24-hour urine collection for catecholamines and metanephrines</strong>. If these are elevated then the diagnosis is confirmed and the next step is <strong>imaging to localize the tumor</strong>. Initial imaging is typically performed with CT or MRI of the abdomen to visualize the adrenal glands. If negative, additional imaging such as MIBG scintigraphy or PET scanning can be done to help detect pheochromocytomas in extra-adrenal areas.<br><br>Pheochromocytoma is associated with several genetic conditions including <strong>Multiple Endocrine Neoplasia type 2 (MEN2), Neurofibromatosis type 1 (NF1), and Von Hippel-Lindau (VHL) disease</strong>. In patients with pheochromocytoma and clinical features suggesting one of these genetic syndromes, <strong>genetic testing</strong> can be used to confirm the diagnosis and guide family counseling. However, this is typically done after biochemical testing and localization of the pheochromocytoma, as timely management of the pheochromocytoma is necessary due to the risks associated with hypertensive emergencies. <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/r496zn5TSRKDZM6cAhjVRef9SSeGgrr0/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ 24-hour urine collection for metanephrines, catecholamines, and metabolites:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ CT scan of the abdomen:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This is an essential step in the workup of a confirmed pheochromocytoma, however, it is not the first step, and biochemical confirmation should precede anatomical localization of the tumor. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ CT scan of the head:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Head CT would be an appropriate test to order if CNS pathology was the suspected cause of the headache. This patient has a constellation of symptoms including headache, palpitations, and diaphoresis along with a normal neurological examination, which is more consistent with a catecholamine-secreting tumor. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Genetic testing for mutations in the VHL gene:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: VHL disease is highly suspected in this patient given her past medical history of retinal angiomas and family history of renal cancer, however, it is not the first step in evaluation. The presence of pheochromocytoma should first be confirmed with biochemical testing. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Genetic testing for mutations in the NF1 gene:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: While NF1 may be associated with pheochromocytomas, the patient's clinical picture and family history align more closely with VHL disease. Biochemical confirmation of a pheochromocytoma should be performed first. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 42-year-old man presents to his primary care physician with worsening fatigue and abdominal pain. His symptoms started several months ago but have worsened to the point where he feels like he cannot function at work. He states, &#8220;I am having so much trouble sleeping; maybe I am depressed.&#8221; Their past medical history is notable for hypothyroidism, for which he takes levothyroxine. He does not consume alcohol, tobacco, or recreational substances. Temperature is 37.0&#176;C, blood pressure is 110/75 mmHg, and pulse is 72/min. Laboratory testing is shown below. Physical examination is notable for skin hyperpigmentation. Which medications are most appropriate for treating this patient&#8217;s clinical condition? &#160;<br><br><table><tbody><tr><td>&#160;<strong>Laboratory Value&#160;</strong></td><td>&#160;<strong>Result</strong>&#160;</td></tr><tr><td>&#160;Sodium&#160;</td><td>&#160;130 mEq/L&#160;</td></tr><tr><td>&#160;Potassium&#160;</td><td>&#160;5.1 mEq/L&#160;</td></tr><tr><td>&#160;Chloride&#160;</td><td>&#160;100 mEq/L&#160;</td></tr><tr><td>&#160;Bicarbonate&#160;</td><td>&#160;26 mEq/L&#160;</td></tr><tr><td>&#160;Thyroid stimulating hormone&#160;</td><td>&#160;3.2 &#181;U/mL&#160;</td></tr><tr><td>&#160;Free T4&#160;</td><td>&#160;10 &#181;g/dL&#160;</td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "choices": [
        {
          "id": 1,
          "text": "Fludricortisone&#160;"
        },
        {
          "id": 2,
          "text": "Spironolactone&#160;"
        },
        {
          "id": 3,
          "text": "Prednisone&#160;"
        },
        {
          "id": 4,
          "text": "Liothyronine"
        },
        {
          "id": 5,
          "text": "Metyrapone"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient with a history of hypothyroidism presents with chronic fatigue, non-specific abdominal pain, and hyperpigmentation. Laboratory testing is notable for hyperkalemia, hyponatremia, and normal thyroid function tests. These findings are consistent with primary adrenal insufficiency (Addison disease). The most appropriate treatment for this condition is <strong>fludrocortisone</strong>, which has significant mineralocorticoid activity. &#160; &#160;<br><br>Mineralocorticoids are a class of corticosteroids that primarily influence salt and water balance. Physiologically, the primary mineralocorticoid in the human body is <strong>aldosterone</strong>. The primary synthetic mineralocorticoid in use is <strong>fludrocortisone</strong>, which is recombinant aldosterone. Additional medications such as hydrocortisone or prednisone have some mineralocorticoid activity. However, they also possess glucocorticoid activity, making them less potent agents in treating hypoaldosteronism. &#160; <br><br>Mineralocorticoids work by mimicking the effects of aldosterone via increasing the retention of sodium and water and excretion of potassium and hydrogen ions into the cortical <strong>collecting tubule</strong> of the kidney. They are used primarily in the treatment of hypoaldosteronism but are also utilized in the treatment of <strong>congenital adrenal hyperplasia.</strong> Adverse side effects include <strong>hypokalemia, hypertension,&#160;</strong>and <strong>weight gain</strong> due to water retention.<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Fludricortisone&#160;:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Spironolactone&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Spironolactone carries anti-mineralocorticoid effects, which would make this patient&#8217;s primary hyperaldosteronism worse.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Prednisone&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Prednisone has some mineralocorticoid activity. However, it is primarily a glucocorticoid. In contrast, fludrocortisone is a more appropriate treatment for this patient&#8217;s primary hypoaldosteronism.</span></div><div style='margin-bottom: 12px;'><strong>❌ Liothyronine:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>While this patient has a history of hypothyroidism, his thyroid function tests are within normal limits. As a result, it is unlikely that his current symptoms are secondary to hypothyroidism.</span></div><div style='margin-bottom: 12px;'><strong>❌ Metyrapone:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Metyrapone is a pyridine derivative and a glucocorticoid synthesis inhibitor. The medication is used to aid in diagnosing, not treating, primary adrenal insufficiency.&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 31-year-old man presents to his primary care physician for a routine check-up. During the evaluation, the patient is found to have a blood pressure of 158/94 mmHg. At a follow-up visit two weeks later, his blood pressure is 163/71 mmHg. He does not consume alcohol, tobacco, or recreational substances. Past medical history is unremarkable. Initial labs from this second office visit are demonstrated below. Based on this information, treatment for this patient&#8217;s condition would most likely involve a medication that acts via which of the following mechanisms? &#160;<br><br><table><tbody><tr><td>&#160;<strong>Laboratory Value&#160;</strong></td><td>&#160;<strong>Result&#160;</strong></td></tr><tr><td>&#160;<strong>Serum Chemistry&#160;</strong></td></tr><tr><td>&#160;Sodium &#160;</td><td>&#160;147 mEq/L&#160;</td></tr><tr><td>&#160;Potassium &#160;</td><td>&#160;2.9 mEq/L&#160;</td></tr><tr><td>&#160;Chloride&#160;</td><td>&#160; 95 mEq/L&#160;</td></tr><tr><td>&#160;Creatinine &#160;</td><td>&#160;1.1 mg/dL&#160;</td></tr><tr><td>&#160;Bicarbonate &#160;</td><td>&#160;36 g/dL&#160;</td></tr><tr><td>&#160;Calcium &#160;</td><td>&#160;8.6 mg/dL&#160;</td></tr><tr><td>&#160;Glucose&#160;</td><td>&#160;84 mg/dL&#160;</td></tr><tr><td>&#160;<strong>Serum Blood Gas &#160;</strong></td></tr><tr><td>&#160; &#160; &#160; &#160; &#160; &#160;pH&#160;</td><td>&#160; &#160; &#160; &#160; &#160; &#160; &#160; 7.57&#160;</td></tr><tr><td>&#160; &#160; &#160; &#160; &#160; &#160;pCO2&#160;</td><td>&#160; &#160; &#160; &#160; &#160; &#160; 44 mm Hg&#160;</td></tr><tr><td>&#160; &#160; &#160; &#160; &#160; &#160; Po<span>2</span>&#160;</td><td>&#160; &#160; &#160; &#160; &#160; &#160; 100 mm Hg&#160;</td></tr><tr><td>&#160; &#160; &#160; &#160; &#160; &#160;HCO3<span>-</span>&#160;</td><td>&#160; &#160; &#160; &#160; &#160; &#160; &#160;36 mEq/L&#160;</td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "choices": [
        {
          "id": 1,
          "text": "Inhibition of the Na+ and Cl- transporter"
        },
        {
          "id": 2,
          "text": "Antagonism of mineralocorticoid receptors"
        },
        {
          "id": 3,
          "text": "Inhibition of carbonic anhydrase"
        },
        {
          "id": 4,
          "text": "Inhibition of the Na+-K+-2Cl- symporter"
        },
        {
          "id": 5,
          "text": "Inhibition of the angiotensin-converting enzyme&#160;"
        }
      ],
      "correct_choice_id": 2,
      "solution": "This patient presents with hypertension in the setting of metabolic alkalosis (pH 7.57 with a concomitant increase in bicarbonate), hypernatremia, and hypokalemia. These findings are suggestive of <strong>primary hyperaldosteronism.&#160;</strong>This condition is characterized by excessive aldosterone production, resulting in sodium and water retention and hypokalemic metabolic alkalosis secondary to the excretion of potassium and hydrogen ions into the urine. Treatment of primary hyperaldosteronism involves <strong>aldosterone receptor antagonists,</strong> such as <strong>spironolactone&#160;</strong>and <strong>eplerenone</strong>. &#160; <br><br>Primary hyperaldosteronism is often due to an <strong>aldosterone-secreting adenoma&#160;</strong>(Conn syndrome), especially in young and otherwise healthy patients. Secondary hyperaldosteronism can be due to etiologies, including renovascular hypertension, renin-producing juxtaglomerular cell tumor, and edematous states such as heart failure. &#160; &#160;<br><br>Regardless, medical therapy aims to normalize the serum potassium level and blood pressure and reverse the effects of hyperaldosteronism on the heart. Thus, therapy should be targeted at <strong>antagonizing mineralocorticoid receptors</strong> using medications. These medications will ultimately prevent additional sodium reabsorption and hydrogen ion and potassium wasting. &#160; <br><br>The primary side effect of these medications is <strong>hyperkalemia</strong>, which can cause dangerous arrhythmias. Spironolactone can also cause <strong>antiandrogen effects</strong>, resulting in gynecomastia and decreased sex drive.<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Inhibition of the Na+ and Cl- transporter:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Thiazides (e.g., hydrochlorothiazide, chlorthalidone) are diuretics that act by inhibiting the Na+ and Cl- transporter in the distal convoluted tubule. Although this group of diuretics is indicated for treating patients with essential hypertension, this patient&#8217;s hypokalemia is a contraindication to using these medications.</span></div><div style='margin-bottom: 12px;'><strong>✅ Antagonism of mineralocorticoid receptors:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Inhibition of carbonic anhydrase:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Acetazolamide is a medication that acts by inhibiting carbonic anhydrase. It can be used as a diuretic, antiepileptic, and for the treatment of glaucoma. However, this medication can cause hypokalemia. Administering acetazolamide to this patient would likely worsen his hypokalemia.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Inhibition of the Na+-K+-2Cl- symporter:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Furosemide is a loop diuretic that acts on the Na+-K+-2Cl- symporter in the thick ascending limb of the loop of Henle. This medication is widely used in patients with hypertension. However, this patient&#8217;s laboratory findings of hypernatremia, hypokalemia, and metabolic alkalosis are more concerning for hyperaldosteronism, which can be better treated with an aldosterone receptor antagonist.</span></div><div style='margin-bottom: 12px;'><strong>❌ Inhibition of the angiotensin-converting enzyme&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Captopril is an angiotensin-converting enzyme inhibitor that decreases angiotensin II and consequently decreases the glomerular filtration rate and prevents constriction of efferent arterioles. This patient's metabolic alkalosis and hypokalemia suggest hyperaldosteronism as the etiology of his hypertension. Hence, an aldosterone receptor inhibitor would be more effective than an ACE inhibitor.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    }
  ]
}